What is the guideline-recommended management algorithm for bronchospasm and laryngospasm in pediatric and adult patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Bronchospasm and Laryngospasm: Guideline-Based Algorithms

For laryngospasm, immediately apply continuous positive airway pressure with 100% oxygen while ensuring airway patency, followed by Larson's manoeuvre, and escalate to propofol 1-2 mg/kg IV, then suxamethonium 1 mg/kg IV if hypoxia worsens; for bronchospasm in anaphylaxis, administer adrenaline 50 μg IV (adult) or 1 μg/kg IV (pediatric) as the primary intervention, with salbutamol infusion for persistent cases. 1, 2

LARYNGOSPASM MANAGEMENT ALGORITHM

Prevention Strategies

The risk of laryngospasm peaks during lighter planes of anesthesia 1. Extubate either deeply anesthetized or fully awake—avoid the intermediate stage. Perform suction under direct vision while deeply anesthetized, ensuring the upper airway is clear of debris, then avoid further stimulation until the patient is awake 1.

Topical lidocaine sprayed on vocal cords at induction reduces laryngospasm risk following short procedures 1. Sevoflurane and propofol are the least irritant anesthetic agents 1. Additional preventive adjuncts include IV lidocaine, magnesium, and ketamine 1.

Treatment Algorithm (Adults and Pediatrics)

Step 1: Call for help 1

Step 2: Apply continuous positive airway pressure (CPAP) with 100% oxygen using reservoir bag and facemask while ensuring upper airway patency. Avoid unnecessary upper airway stimulation 1.

Step 3: Larson's manoeuvre - Place the middle finger of each hand in the 'laryngospasm notch' between the posterior border of the mandible and mastoid process while displacing the mandible forward in jaw thrust. Apply deep pressure at this point 1.

Step 4: If laryngospasm persists and/or oxygen saturation is falling:

  • Propofol 1-2 mg/kg IV 1
  • Low doses may be effective in early laryngospasm
  • Larger doses needed for severe laryngospasm or total cord closure

Step 5: Suxamethonium 1 mg/kg IV for worsening hypoxia with continuing severe laryngospasm and total cord closure 1. This provides cord relaxation, permitting ventilation, re-oxygenation, and intubation if necessary.

Step 6: Alternative routes if no IV access:

  • Intramuscular: 2-4 mg/kg 1
  • Intralingual: 2-4 mg/kg 1
  • Intraosseous: 1 mg/kg 1

Step 7: Atropine may be required to treat bradycardia 1.

Step 8: In extremis, consider surgical airway 1.

Critical Pitfall: Post-Obstructive Pulmonary Edema

If unrelieved, laryngospasm can progress to post-obstructive pulmonary edema (>50% of cases), hypoxic cardiac arrest, and death 1. This presents with dyspnea, agitation, cough, pink frothy sputum, and low oxygen saturations 1. It occurs in 0.1% of all general anesthetics, more commonly in young muscular adults (male:female ratio 4:1) 1.


BRONCHOSPASM MANAGEMENT ALGORITHM

In Context of Anaphylaxis (Most Critical Scenario)

Immediate Management - ABC Approach 2:

Step 1: Remove all potential causative agents (IV colloids, latex, chlorhexidine) and maintain anesthesia with inhalational agent if necessary 2.

Step 2: Call for help and note the time 2.

Step 3: Maintain airway and administer 100% oxygen. Intubate and ventilate with oxygen if necessary 2.

Step 4: Elevate patient's legs if hypotensive 2.

Step 5: Administer adrenaline IV immediately 2:

Adult Dosing:

  • Initial dose: 50 μg IV (0.5 ml of 1:10,000 solution) 2
  • Several doses may be required for severe hypotension or bronchospasm
  • Consider adrenaline infusion if multiple doses required (short half-life)

Pediatric Dosing (IV):

  • Prepare 1 ml of 1:10,000 adrenaline per 10 kg body weight 2
  • Titrate starting with 1 μg/kg (one-tenth of syringe contents) 2
  • Children often respond to as little as 1 μg/kg
  • Further dilution may be needed in smaller children

Pediatric Dosing (IM if no IV access):

  • 12 years: 500 μg IM (0.5 ml of 1:1000) 2

  • 6-12 years: 300 μg IM (0.3 ml of 1:1000) 2
  • Up to 6 years: 150 μg IM (0.15 ml of 1:1000) 2

Step 6: Administer saline 0.9% or lactated Ringer's at high rate via large-gauge IV cannula (large volumes may be required) 2.

Secondary Management for Persistent Bronchospasm

Step 7: Administer chlorphenamine 2:

  • Adults: 10 mg IV
  • 6-12 years: 5-10 mg IV
  • 6 months-6 years: 2.5-5 mg IV
  • <6 months: 250 μg/kg IV

Step 8: Administer hydrocortisone 2:

  • Adults: 200 mg IV
  • 6-12 years: 100 mg IV
  • 6 months-6 years: 50 mg IV
  • <6 months: 25 mg IV

Step 9: For persistent bronchospasm despite adrenaline:

  • IV salbutamol infusion 2
  • Metered-dose inhaler via breathing-system connector if available 2
  • Consider IV aminophylline or magnesium sulfate 2

Step 10: Alternative vasopressor (e.g., metaraminol) if blood pressure does not recover despite adrenaline infusion 2.

Step 11: Transfer to Critical Care area 2.

Key Distinction: Bronchospasm vs. Laryngospasm

Bronchospasm presents with expiratory wheeze, prolonged exhalation, or complete silence on auscultation in severe cases, with decreased pulmonary compliance and falling oxygen saturation 3. Laryngospasm presents with inspiratory 'crowing' sound, suprasternal recession ('tracheal tug'), and paradoxical chest/abdomen movements; complete obstruction is silent 1.

Critical Pitfall: Exclude Other Causes

Before treating as primary bronchospasm or laryngospasm, exclude misplaced tracheal tube, equipment failure, airway irritation, endotracheal tube problems, and aspiration of gastric contents 2, 3. Consider laryngospasm and bronchospasm as differential diagnoses when optimizing ventilation 4.

Pediatric-Specific Considerations

Children have higher incidence of laryngospasm (17.4/1000 vs 8.7/1000 in general population) 5, 6. Anesthesia administered by pediatric anesthesiologists is associated with lower incidence 5. IV anesthesia has lower incidence than inhalational anesthesia 5. In pediatric studies, 38% responded to airway repositioning and CPAP alone, 47.6% required muscle relaxants, and 23.8% required intubation 6.

Related Questions

What is the immediate treatment for laryngospasm?
What is the recommended management for tracheobronchospasm with attenuated breath sounds?
Does laryngospasm typically occur after intubation, and what management strategies do clinicians employ in real‑world practice according to expert consensus and observational evidence?
What is the appropriate treatment for a 30-year-old patient with bronchitis who smokes Black & Mild cigars and uses marijuana, presenting with a productive cough of brown and green sputum and requesting cough syrup?
In a 5-year-old with a 6-week persistent dry barking cough that worsens at night and with exercise, without fever or recent infection, and a family history of asthma, is this cough-variant asthma and what initial diagnostic and therapeutic steps are recommended?
Which laboratory tests should be ordered for a patient with low INR and low prothrombin?
What does a low INR (International Normalized Ratio) with low prothrombin level and prolonged activated partial thromboplastin time (aPTT) indicate?
Why might a patient with an intact uterus be able to receive estrogen therapy but be unable to take progesterone?
Why should a transesophageal echocardiogram be repeated when a mobile vegetation was identified on a study performed one month ago?
What is the appropriate next step in managing a 20-year-old with regurgitation and belching who has not responded to omeprazole 20 mg and added famotidine (Pepsid)?
What is the recommended initial management for an intrasubstance tear of the infraspinatus at the musculotendinous junction with cystic formation within the tear?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.